Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

14 hours ago 1
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

Related

Renault boss De Meo leaves carmaker to lead Kering, Le Figaro reports

Renault boss De Meo leaves carmaker to lead Kering, Le Figar...

3 hours ago 0
Exclusive-US Export-Import Bank considers $120 million loan for Greenland rare earths project

Exclusive-US Export-Import Bank considers $120 million loan ...

3 hours ago 0
Estee Lauder chairman emeritus Leonard Lauder dies, company says

Estee Lauder chairman emeritus Leonard Lauder dies, company ...

4 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. mclaren
2. zoe saldana
3. jeff gordon
4. giuliano simeone
5. chris gotterup
6. rafael devers
7. washington spirit vs portland thorns
8. kai cenat
9. katherine legge
10. f1 vote

Popular

Hong Kong Joins Global Race With New Stablecoin Licensing Bill

Hong Kong Joins Global Race With New Stablecoin Licensing Bi...

3 weeks ago 414
What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 months ago 241
Stanford 2025 AI Index Reveals Surge in Adoption, Investment, and Global Impact as Trust and Regulation Lag Behind

Stanford 2025 AI Index Reveals Surge in Adoption, Investment...

2 months ago 196
Western Governors University Joins Open edX as a Mission-Aligned Organization

Western Governors University Joins Open edX as a Mission-Ali...

2 months ago 176
Microsoft Adds New Agentic AI Tools to Security Copilot

Microsoft Adds New Agentic AI Tools to Security Copilot

2 months ago 174
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved